Myco-synthesis of selenium nanoparticles and their anticancer properties: a review

Morenikeji Abel Oke1,2,3,4, Elijah Adegoke Adebayo1,2,3, Malik Maaza1,2

  • 1UNESCO-UNISA-ITLABS/NRF Africa Chair in Nanosciences & Nanotechnology, School of Interdisciplinary Research & Graduate Studies (SIRGS0, College of Graduate Studies (CGS), University of South Africa (UNISA), Muckleneuk Ridge, PO Box 392, Pretoria, South Africa.

Nanotechnology
|April 28, 2026
PubMed

Insights

Fungi can be programmed as bio-factories to create selenium nanoparticles (SeNPs) with significant anticancer properties. This review explores myco-synthesis of SeNPs, their mechanisms, and therapeutic potential.

Area of Science:

  • Nanobiotechnology
  • Mycology
  • Cancer Therapeutics

Background:

  • Cancer treatment faces challenges due to uncontrolled growth, immune evasion, and drug resistance.
  • Biogenically synthesized selenium nanoparticles (SeNPs) show promise for anticancer applications.
  • Fungi offer a safe, eco-friendly, and efficient platform for nanoparticle synthesis (myco-synthesis).

Purpose of the Study:

  • To critically review the myco-synthesis of SeNPs.
  • To explore the anticancer potential of myco-synthesized SeNPs.
  • To link fungal properties to SeNP characteristics and anticancer efficacy.

Main Methods:

  • Comprehensive literature review on myco-synthesis of SeNPs.
  • Comparative analysis of fungal species, synthesis conditions, and biomolecules.
  • Investigation of extracellular vs. intracellular synthesis pathways.

Main Results:

  • Fungi serve as effective bio-factories for SeNP production.
  • Myco-synthesized SeNPs exhibit promising anticancer properties.
  • Fungal synthesis conditions influence SeNP characteristics and efficacy.

Conclusions:

  • Myco-synthesis provides a sustainable route to anticancer SeNPs.
  • Understanding synthesis pathways enhances SeNP therapeutic potential and biosafety.
  • Evidence supports the translational application of myco-synthesized SeNPs in cancer therapy.